All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
ABBV total return snapshot: ABBV returned +37.09% over the past year and +14.01% YTD, with dividends reinvested. Since Dec. 10, 2012, ABBV is up +1,150.92% in nominal total return, or +20.42%/yr, and is currently −1.83% below its total-return high on Jul. 2, 2026.
Data ending Fri Jul. 17, 2026
| Mon 2012-12-10💬 to Fri 2026-07-17 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| ABBV × |
+14.01%
2026-07-17 |
+37.09%
2026-07-17 |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Mon 2012-12-10💬 to Fri 2026-07-17 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| ABBV × |
+1,150.92%
+20.42%/yr |
+17.77%/yr
(R2=0.963) |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Mon 2012-12-10💬 to Fri 2026-07-17 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| ABBV × |
$10,000.00
2012-12-10 |
$125,091.55
2026-07-17 |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Year | ABBV |
|---|---|
| 2026 (YTD) | +14.01% |
| 2025 | +33.08% |
| 2024 | +18.87% |
| 2023 | −0.23% |
| 2022 | +24.01% |
| 2021 | +32.43% |
| 2020 | +27.72% |
| 2019 | +1.47% |
| 2018 | −0.96% |
| 2017 | +60.07% |
| 2016 | +9.79% |
| 2015 | −6.50% |
| 2014 | +27.92% |
| 2013 | +60.77% |
| 2012 | −2.40% |
| Mon 2012-12-10💬 to Fri 2026-07-17 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| ABBV × |
−1.83%
from 2026-07-02 peak |
−45.09%
2019-08-15 from 2018-01-26 peak |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Period ending Fri 2026-07-17 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| ABBV × | +37.09% |
+55.07% +24.53%/yr |
+109.36% +27.93%/yr |
+160.23% +21.08%/yr |
+505.91% +19.74%/yr |
|
| AbbVie Inc NYSE Common Stock | ||||||
